Stay updated on Ampyra Optic Neuritis in MS Clinical Trial
Sign up to get notified when there's something new on the Ampyra Optic Neuritis in MS Clinical Trial page.

Latest updates to the Ampyra Optic Neuritis in MS Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2 (site maintenance/update). No study content, endpoints, or eligibility criteria were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the government funding notice that warned updates may not be up to date and that operations could be affected; the page no longer displays the NIH Clinical Center operating status guidance.SummaryDifference0.4%

- Check49 days agoChange DetectedNo additions or deletions detected on the page; the content appears unchanged.SummaryDifference0.4%

- Check70 days agoChange DetectedMajor update to page status: announces a funding lapse impact and that the NIH Clinical Center is open, plus a new version v3.2.0; removes the old v3.1.0.SummaryDifference2%

- Check78 days agoChange DetectedPage now shows revision to v3.1.0 and removes several drug-safety-related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content, indicating a shift away from those topics while adding a new version.SummaryDifference0.3%

- Check92 days agoChange DetectedThe page has been updated to revision v3.0.2, replacing v3.0.1. A 'Back to Top' link was removed.SummaryDifference0.1%

Stay in the know with updates to Ampyra Optic Neuritis in MS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ampyra Optic Neuritis in MS Clinical Trial page.